Related Experiment Videos
Cholesterol and hepatic lipoprotein assembly and secretion.
1Mammalian Cell and Molecular Biology Lab, Department of Biology, The Molecular Biology Institute, San Diego State University, San Diego, California 92182-0057, USA.
Biochimica Et Biophysica Acta
|December 9, 2000
Summary
Liver cholesterol metabolism and very-low-density lipoprotein (VLDL) secretion are linked by sterol response element binding proteins (SREBP). Metabolic zonal segregation in the liver may prevent competition between bile acid synthesis and VLDL assembly.
Area of Science:
- Biochemistry
- Molecular Biology
- Hepatology
Background:
- Hepatic very-low-density lipoprotein (VLDL) assembly and secretion are critical for cholesterol transport.
- Cholesterol metabolism, including biosynthesis and bile acid conversion, is tightly regulated.
- Low-density lipoprotein (LDL) receptors mediate cellular cholesterol uptake.
Purpose of the Study:
- To elucidate the interrelationship between hepatic cholesterol metabolism and VLDL assembly/secretion.
- To investigate the role of sterol response element binding proteins (SREBP) in coordinating these pathways.
- To explore the potential impact of metabolic zonal segregation within the liver.
Main Methods:
- Analysis of gene expression and enzyme activity related to cholesterol metabolism and VLDL production.
- Studies in hepatoma cells overexpressing CYP7A1 (bile acid synthesis enzyme).
- Examination of SREBP transcription factor activity and its gene targets.
Main Results:
- Coordinate regulation of cholesterol biosynthetic/catabolic enzymes and VLDL assembly/secretion is mediated by SREBP transcription factors.
- Overexpression of CYP7A1 leads to increased mature SREBP1, inducing lipogenesis and VLDL assembly/secretion.
- Evidence suggests a link between bile acid synthesis and VLDL assembly/secretion pathways via SREBP-dependent transcription.
Conclusions:
- The bile acid synthetic pathway and VLDL assembly/secretion pathway are coordinately regulated by SREBP-dependent transcription.
- Metabolic zonal segregation in the liver (e.g., differential expression of CYP7A1 and HMG-CoA reductase) may play a role in coordinating these functions.
- This coordination may prevent metabolic antagonism, such as competition for cholesterol, between pathways.